TAG ARCHIVE

POSTS TAGGED AS biotechnology

Maryland’s “City of Science”

June 15, 2010 | Terry Sharrer | Posted in Newsletter

Unless the neighbors make a case against increased road traffic, a new $10b science city will proceed in Shady [MORE]

Medical Device Provides Smarter Quality of Life

February 16, 2010 | Terry Sharrer | Posted in Newsletter

The University of Bologne is carrying out a large study of patients with mobility and movement functions using McRoberts’ [MORE]

Biomarker Test for Heart Attack

December 21, 2009 | Terry Sharrer | Posted in Newsletter

In acquiring BRAHMS (Hennigsdorf, Germany) last October, Thermo Fisher Scientific (Waltham, MA) took over marketing of BRAHMS’s blood biomarker [MORE]

Newborn Screening

December 14, 2009 | Terry Sharrer | Posted in Newsletter

PerkinElmer (Waltham, MA and Fremont, CA) has introduced an automated platform that quantitatively and qualitatively analyzes neonate blood samples [MORE]

Google Looking for Investments Opportunities

November 10, 2009 | Terry Sharrer | Posted in Newsletter

Search engine giant, Google, has launched Google Ventures (Cambridge, MA and Mountain View, CA) to fund investments [MORE]

Aneesh Chopra Appointed Chief Technology Officer

August 11, 2009 | Terry Sharrer | Posted in Newsletter

At the 2008 Medical Automation Conference, then Secretary of Technology for the Commonwealth of Virginia, Aneesh Chopra, gave a keynote address [MORE]

Pharmas’ Research Investments

May 31, 2009 | Terry Sharrer | Posted in Newsletter

The US economy may be contracting sharply in some industries, but drug makers spent $2b more on research in 2008 [MORE]

Patenting “Biosimilars”

May 27, 2009 | Terry Sharrer | Posted in Newsletter

Several bills now in Congress could result in a fundamental change to patenting biologics (such as monoclonal antibodies).  One bill [MORE]

Ambient Assisted Living

May 19, 2009 | Terry Sharrer | Posted in Newsletter

PERSONA, a project of the European Union that promotes independent aging, has been functioning since 2007 and will continue until [MORE]

Vector: Smart Capsule

March 31, 2009 | Terry Sharrer | Posted in Newsletter

Thomas Lango, an engineer with SINTEF-a large independent research organization in Norway-have been working with physicians to develop a “smart [MORE]

The $100 Genome

March 24, 2009 | Terry Sharrer | Posted in Newsletter

No, the $1,000 genome has not yet seen the light of day, but hardly a week goes by without hearing [MORE]

SomnoSENS and More

March 17, 2009 | Terry Sharrer | Posted in Newsletter

Researchers at the Fraunhofer Institute for Integrated Circuits in Erlangen, Germany had developed a mobile sleep lab for home assessment, [MORE]

Snakebots

February 3, 2009 | Terry Sharrer | Posted in Newsletter

Engineering a robotic arm that has snakelike flexibility is no small matter, but that’s what Professor Howie Choset, at Carnegie [MORE]

FDA Approved Five More i-STAT Tests

January 28, 2009 | Terry Sharrer | Posted in Newsletter

Abbott’s i-STAT handheld blood analyzer has just received an FDA waiver for five more tests using its 18 cartridges, which [MORE]

Designing Drug-Eluting Stents

January 28, 2009 | Terry Sharrer | Posted in Newsletter

There are currently only four drug-eluting stents under FDA approval, and their effectiveness or ineffectiveness have been called into question.  [MORE]

Non-invasive Glucose Monitoring

January 20, 2009 | Terry Sharrer | Posted in Newsletter

Solianis Monitoring AG (Zurich, Switzerland) has recently completed a study of its wearable, noninvasive, multisensor glucose monitor that tracks blood [MORE]

Big $ R&D Spenders

January 13, 2009 | Terry Sharrer | Posted in Newsletter

Genetic Engineering & Biotechnology News reported recently that GSK’s deal with Actelion, worth almost $3.2 billion, for Actelion’s insomnia drug [MORE]

Emerging Markets for Advanced Biomaterials

December 9, 2008 | Terry Sharrer | Posted in Newsletter

BioWorld Today and Medical Devices Daily has a 200 page market analysis (cost $599) for biomaterials, covering such things as [MORE]